Compound Library

Peptide / Pain/Recovery

Conolidine (CGRP inhibitor)

Natural alkaloid analgesic from Tabernaemontana divaricata. Inhibits CGRP receptor — the same target as migraine drugs. Non-opioid pain relief. Anti-inflammatory. Emerging research compound.

Build protocol outline Open dose calculator TNHL ebooks
Educational reference only. This page does not diagnose, prescribe, or replace care from a licensed professional. Laws, availability, and clinical appropriateness vary by location.
Reference dose10–30mg oral daily.
Half-life4 hours
Risk flaglow
Regulatory noteResearch-only flag

Side effects and watch-outs

  • Limited human data
  • GI upset
  • Headache
  • Generally well tolerated in early research